Open AccessNeuroprotective effects of new compounds directed to PP2A, a promising therapeutic target for Alzheimer’s disease.
Author(s) -
Raquel López Arribas,
Rocío Lajarín Cuesta,
Cristóbal de los Ríos Salgado,
Cristóbal de los Ríos Salgado
Publication year - 2018
Publication title -
ibj plus
Language(s) - English
Resource type - Journals
ISSN - 2531-0151
DOI - 10.24217/2531-0151.18v1s1.00025
Subject(s) - neuroprotection , disease , medicine , alzheimer's disease , neuroscience , pharmacology , biology